Pharming Group Q1 2026 Earnings Missed EPS Estimates Amid Operational Challenges IVV vs VOO Why 10 Basis Points Matter and Securities Lending Gives iShares the Edge Zepp Health Q3 2025 Earnings Narrowing Losses Drive Modest Stock Uplift Stephen Miran Departs Federal Reserve Paving Way for Kevin Warshs Leadership NXPL Q1 2026 Earnings Loss Per Share Narrows as Stock Gains on Strategic Progress PATH Q1 2026 Earnings EPS Surges Past Estimates Stock Slips Catalyst Pharmaceuticals Q1 2026 Earnings EPS Surpasses Estimates by 75